OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Editorial Board	120
Authors’ reply to comments on “Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt”	117
In-situ sequential crystallization of fenofibrate and tristearin – Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallizatio	116
Double-layer dissolving microneedles for delivery of mesenchymal stem cell Secretome: Formulation, characterisation and skin irritation study	112
Editorial Board	94
Liquid crystal phase formation and non-Newtonian behavior of oligonucleotide formulations	88
Editorial Board	86
Harnessing dicarboxylate-based salts for enhancing the performance of amorphous solid dispersions: The case of olanzapine	74
Topical liquid formulation of bacteriophages for metered-dose spray delivery	65
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions	58
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment	57
COSMO models for the pharmaceutical development of parenteral drug formulations	52
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery	50
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration	49
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study	46
Corrigendum to “Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy” [Eur. J. Pharm. Biopharm. 211 (2025) 114714]	45
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans	45
Unravelling the polysorbate 20 composition: A fusion of UPLC-MS analysis and stochastic modelling	44
Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody	43
Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells	42
Long-term exposure in high viscous microenvironment facilitates acquired drug resistance of colon cancer cells to doxorubicin	41
Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response	40
Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids	39
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles	38
Viscosity increase/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes	38

Homogeneity and mechanical properties of orodispersible films loaded with pellets	38
Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps	37
Strain- and species-specific immune responses to human adipose stem cell-derived extracellular vesicles: A comparative pharmacological evaluation in mice and human PBMCs	36
Rationalisation of the purification process for a phage active pharmaceutical ingredient	36
Editorial Board	35
Question-based review for pharmaceutical development: An enhanced quality approach	35
Preparation of thrombin-loaded calcium alginate microspheres with dual-mode imaging and study on their embolic properties in vivo	35
Machine learning driven bioequivalence risk assessment at an early stage of generic drug development	34
Comparing effects of terpene-based deep eutectic solvent and solid microneedles on skin permeation of drugs with varying lipophilicity	34
Effect of the combination of ion-pairs strategies and permeation enhancers on iguratimod transdermal patch against rheumatoid arthritis	34